103476-89-7,
Leupeptin hemisulfate,
Leupeptin hemisulfate salt,
Leupeptin hemisulfate anhydrous,
UNII-05V9Y5208M,
05V9Y5208M,
55123-66-5,
MFCD00037012,
L-Leucinamide, N-acetyl-L-leucyl-N-((1S)-4-((aminoiminomethyl)amino)-1-formylbutyl)-, sulfate (2:1),
leupeptin sulfate,
N-Acetyl-L-leucyl-L-leucyl-L-argininal hemisulfate salt,
leupeptin-hemisulfate,
Leupeptin (hemisulfate),
AC1MBZ1F,
Leupeptin hydrogen sulphate,
Leupeptin, >4000 U/mg,
CHEBI:90629,
Leupeptin Hemisulphate, Synthetic,
AKOS024418728,
Leupeptin, microbial, >=90% (HPLC),
Leupeptin, synthetic, >=85% (HPLC),
A14145,
Acetyl-L-leucyl-L-leucyl-L-argininal hemisulfate,
Leupeptin, BioUltra, microbial, >=95% (HPLC),
Leupeptin, Ac-Leu-Leu-argininal x 1/2 H2SO4, synthetic,
N-acetyl-L-leucyl-N-[(2S)-5-carbamimidamido-1-oxopentan-2-yl]-L-leucinamide sulfate (2:1),
(2S)-2-acetamido-N-[(2S)-1-[[(2S)-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]-4-methylpentanamide; sulfuric acid,
bis{N-acetyl-L-leucyl-N-[(2S)-5-{[azaniumyl(imino)methyl]amino}-1-oxopentan-2-yl]-L-leucinamide} sulfate,
Leupeptin,
Leupeptin, Microbial,
Acetyl-Leu-Leu-Arg-al,
UNII-J97339NR3V,
Leupeptin hemisulfate monohydrate,
LEUPEPTINHEMISULFATEMONOHYDRATE,
C20-H38-N6-O4,
CID2733491,
CID 2733491,
(S)-2-(2-Acetamido-4-methylvaleramido)-N-(1-formyl-4-guanidinobutyl)-4-methyl-valeramide,
L-Leucinamide, N-acetyl-L-leucyl-N-[(1S)-4-[(aminoiminomethyl)amino]-1-formylbutyl]-, sulfate (2:1),
Leupeptin hemisulfate salt, 90%, reversible competitive serine/cysteine protease inhibitor - 100MG 100mg,
Valeramide, 2-(2-acetamido-4-methylvaleramido)-N-(1-formyl-4-guanidinobutyl)-4-methyl- (S)-,